Abstract:The gold standard for treating peripheral nerve injuries that have large nerve gaps where the nerves cannot be directly sutured back together because it creates tension on the nerve, is to incorporate an autologous nerve graft. However, even with the incorporation of a nerve graft, generally patients only regain a small portion of function in limbs affected by the injury. Although, there has been some promising results using growth factors to induce more axon growth through the nerve graft, many of these previous therapies are limited in their ability to release growth factors in a sustained manner and tailor them to a desired time frame. The ideal drug delivery platform would deliver growth factors at therapeutic levels for enough time to grow axons the entire length of the nerve graft. We hypothesized that mineral coated microparticles (MCMs) would bind, stabilize and release biologically active glial cell-derived neurotrophic factor (GDNF) and nerve growth factor (NGF) in a sustained manner. Therefore, the objective of this study was to test the ability of MCMs releasing growth factors at the distal end of a 10 mm sciatic nerve graft, to induce axon growth through the nerve graft and restore hind limb function. After sciatic nerve grafting in Lewis rats, the hind limb function was tested weekly by measuring the angle of the ankle at toe lift-off while walking down a track. Twelve weeks after grafting, the grafts were harvested and myelinated axons were analyzed proximal to the graft, in the center of the graft, and distal to the graft. Under physiological conditions <i>in vitro</i>, the MCMs delivered a burst release of NGF and GDNF for 3 days followed by a sustained release for at least 22 days. <i>In vivo</i>, MCMs releasing NGF and GDNF at the distal end of sciatic nerve grafts resulted in significantly more myelinated axons extending distal to the graft when compared to rats that received nerve grafts without growth factor treatment. The rats with nerve grafts incorporated with MCMs releasing NGF and GDNF also showed significant improvement in hind limb function starting at 7 weeks postoperatively and continuing through 12 weeks postoperatively when compared to rats that received nerve grafts without growth factor treatment. In conclusion, MCMs released biologically active NGF and GDNF in a sustained manner, which significantly enhanced axon growth resulting in a significant improvement of hind limb function in rats. The animal experiments were approved by University of Wisconsin-Madison Animal Care and Use Committee (ACUC, protocol# M5958) on January 3, 2018.

Implantation of Neurotrophic Factor-Treated Sensory Nerve Graft Enhances Survival and Axonal Regeneration of Motoneurons after Spinal Root Avulsion

Neurotrophic Factor Treatment after Spinal Root Avulsion Injury.

Motor Nerve Graft is Better Than Sensory Nerve Graft for Survival and Regeneration of Motoneurons after Spinal Root Avulsion in Adult Rats

Delayed implantation of a peripheral nerve graft reduces motoneuron survival but does not affect regeneration following spinal root avulsion in adult rats.

Combination Treatment With Exogenous GDNF and Fetal Spinal Cord Cells Results in Better Motoneuron Survival and Functional Recovery After Avulsion Injury With Delayed Root Reimplantation.

Improved Axonal Regeneration of Transected Spinal Cord Mediated by Multichannel Collagen Conduits Functionalized with Neurotrophin-3 Gene

Ventral root re-implantation is better than peripheral nerve transplantation for motoneuron survival and regeneration after spinal root avulsion injury

BDNF guides neural stem cell-derived axons to ventral interneurons and motor neurons after spinal cord injury

Single Injection of a Novel Nerve Growth Factor Coacervate Improves Structural and Functional Regeneration after Sciatic Nerve Injury in Adult Rats.

Survival of injured spinal motoneurons in adult rat upon treatment with glial cell line-derived neurotrophic factor at 2 weeks but not at 4 weeks after root avulsion.

Neurotrophic Factor Gene Delivery Supports Axonal Regeneration after Injury

Neural Progenitor Cells Enhance the Survival and Axonal Regeneration of Injured Motoneurons after Transplantation into the Avulsed Ventral Horn of Adult Rats

Survival and regeneration of motoneurons in adult rats by reimplantation of ventral root following spinal root avulsion.

GDNF and BDNF alter the expression of neuronal NOS, c-Jun, and p75 and prevent motoneuron death following spinal root avulsion in adult rats.

Functional recovery after peripheral nerve injury via sustained growth factor delivery from mineral-coated microparticles

Transplantation of NEP1-40 and NT-3 Gene-Co-Transduced Neural Stem Cells Improves Function and Neurogenesis after Spinal Cord Injury in a Rat Model.

Transplantation of Embryonic Spinal Cord Neurons to the Injured Distal Nerve Promotes Axonal Regeneration after Delayed Nerve Repair.

Controlled Release of Ciliary Neurotrophic Factor from Bioactive Nerve Grafts Promotes Nerve Regeneration in Rats with Facial Nerve Injuries

Transplantation of Artificial Neural Construct Partly Improved Spinal Tissue Repair and Functional Recovery in Rats with Spinal Cord Transection

Neural Stem Cells Enhance Nerve Regeneration after Sciatic Nerve Injury in Rats

Optimal Time Point for Neuronal Generation of Transplanted Neural Progenitor Cells in Injured Spinal Cord Following Root Avulsion